FTC sues main pharmacy advantage managers around insulin price ranges The company introduced action towards Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the checklist price of life-preserving insulin medicine. Sanders quickly condemned the move in an announcement Wednesday, noting he was disappointed https://kethek.com/